Vietnam

Vietnam has rapidly transformed into a high-growth hub for the global life sciences ecosystem, driven by a robust pharmaceutical industry and a burgeoning biotechnology sector.

Strategically positioned in Southeast Asia, the country is best known for its expanding generic drug manufacturing capabilities and its increasingly sophisticated biopharmaceutical R&D landscape.

Recent government initiatives, such as Resolution 57, have catalyzed public-private partnerships, accelerating healthcare innovation and the adoption of AI-driven drug discovery.

Vietnam's medical device market is also witnessing double-digit growth, fueled by the National Digital Transformation Program and a rising demand for telemedicine and high-tech diagnostic equipment.

Furthermore, the country is becoming a preferred destination for international clinical trials, offering a large patient pool and streamlined regulatory frameworks under the new Circular 50/2025/TT-BYT.

Academic research institutions, particularly in major cities like Ho Chi Minh City and Hanoi, are deepening their focus on regenerative medicine and bioinformatics to address regional health challenges.

With a focus on regulatory compliance and international quality standards like GMP, Vietnam is successfully attracting significant foreign direct investment (FDI) from global healthcare leaders.

As the population ages, the demand for specialized oncology, biologics and chronic disease management continues to rise, positioning Vietnam as a critical node in the global medical supply chain.

This dynamic environment, supported by a skilled workforce and modernizing healthcare infrastructure, ensures Vietnam remains a premier frontier for life sciences expansion in 2026.